Licensed Practical Nurse in Fallon, NV Accepting Medicare

3 Licensed Practical Nurse nurses found. Showing 1 - 3

Jessica Rae Hopkins, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5550 Candee Ln, Fallon, NV 89406 Phone: 307-221-1865

Sharon Ann Shirley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 Rio Vista Dr, Fallon, NV 89406 Phone: 775-423-3634

Ms. Esther Elizabeth King, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 Rio Vista St, Fallon, NV 89406 Phone: 775-423-3634    Fax: 775-423-3246

News Archive

New research identifies novel cellular factors vital for CCHFV infection

New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), a tick-borne virus which causes a severe hemorrhagic disease in humans similar to that caused by Ebolavirus, has identified new cellular factors essential for CCHFV infection.

EORTC hosts joint session with ESTRO to focus on latest developments in soft tissue sarcoma treatment

The EORTC will host a joint session with ESTRO at ESTRO 33 focusing on current developments in soft tissue sarcoma treatment. It will take place from 14:30- 16:00 on Monday, 07 April 2014 in Vienna, Austria and will be co-chaired by Professors Jean-Yves Blay of the Centre Leon Berard in Lyon, France and past EORTC President and Philippe Maingon of the Centre Georges-Fran-ois-Leclerc in Dijon, France, and Chair of the EORTC Radiation Oncology Group.

Promotional speaker programs on the latest drug developments help pharma companies attract physicians

In response to increased political and regulatory scrutiny, pharmaceutical companies are rebranding their promotional speaker programs as unparalleled opportunities for physicians to learn or remain current on the latest drug developments and to network with colleagues. The rebranding is helping to attract physicians who are more interested in learning than in getting a free meal. It is also working to improve program ROI and lessen pressures from outside agencies that feel the meetings are payoffs for prescriptions.

GTx reports top line results from toremifene Phase III clinical trial for prostate cancer

GTx, Inc. today announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate.

Read more Medical News

› Verified 8 days ago